Intestinal alkaline phosphatase administration in newborns is protective of gut barrier function in a neonatal necrotizing enterocolitis rat model

Journal of Pediatric Surgery

Volumn 47, Issue 6, 2012, Pages 1135-1142

  Rentea, Rebecca M ^a   Liedel, Jennifer L ^a   Welak, Scott R ^a   Cassidy, Laura D ^a   Mayer, Alan N ^b   Pritchard, Kirkwood A ^a   Oldham, Keith T ^a   Gourlay, David M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dose response; Gut barrier; Intestinal alkaline phosphatase; Necrotizing enterocolitis; Tight junction

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE INTESTINE ISOENZYME; CLAUDIN 1; CLAUDIN 3; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; LIPOPOLYSACCHARIDE; MESSENGER RNA; OCCLUDIN; PROTEIN ZO1; UNCLASSIFIED DRUG; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BREAST FEEDING; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HOMOGENATE; HYPOXIA; INTESTINE EPITHELIUM; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VAGINAL DELIVERY; DOSE RESPONSE; INTESTINE; PERMEABILITY BARRIER; PROTECTION;

EID: 84862490925     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2012.03.018     Document Type: Conference Paper

References (37)

1. Christensen RD, Gordon PV, Besner GE. Can we cut the incidence of necrotizing enterocolitis in half-today? Fetal Pediatr Pathol 2010;29: 185-98.
2. Sankaran K, Puckett B, Lee DS, et al. Variations in incidence of necrotizing enterocolitis in Canadian neonatal intensive care units. J Pediatr Gastroenterol Nutr 2004;39:366-72.
3. Guillet R, Stoll BJ, Cotten CM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006;117:e137-42. (Pubitemid 46071566)
4. Holman RC, Stoll BJ, Curns AT, et al. Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol 2006;20:498-506. (Pubitemid 44581549)
5. Llanos AR, Moss ME, Pinzon MC, et al. Epidemiology of neonatal necrotising enterocolitis: a population-based study. Paediatr Perinat Epidemiol 2002;16:342-9. (Pubitemid 35429356)
6. Fanning AS, Anderson JM. Protein modules as organizers of membrane structure. Curr Opin Cell Biol 1999;11:432-9. (Pubitemid 29396788)
7. Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 2005;21:177-96. (Pubitemid 40386748)
8. Liu Z, Li N, Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr 2005;94:386-93.
9. Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 2007;127:2525-32. (Pubitemid 47585053)
10. Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 2000;279:G851-7.
11. Clark JA, Doelle SM, Halpern MD, et al. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 2006;291: G938-49. (Pubitemid 44772020)
12. Anand RJ, Leaphart CL, Mollen KP, et al. The role of the intestinal barrier in the pathogenesis of necrotizing enterocolitis. Shock 2007;27: 124-33. (Pubitemid 46105827)
13. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 2006;55:1512-20. (Pubitemid 44476799)
14. Han X, Fink MP, Delude RL. Proinflammatory cytokines cause NO*- dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 2003;19:229-37.
15. Neu J, Chen M, Beierle E. Intestinal innate immunity: how does it relate to the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 2005;14:137-44. (Pubitemid 41111599)
16. Shiou SR, Yu Y, Chen S, et al. Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis. J Biol Chem 2011.
17. Beumer C, Wulferink M, Raaben W, et al. Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J Pharmacol Exp Ther 2003;307:737-44. (Pubitemid 37310691)
18. Koyama I, Matsunaga T, Harada T, et al. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin Biochem 2002;35:455-61. (Pubitemid 35284542)
19. Tuin A, Huizinga-Van der Vlag A, van Loenen-Weemaes AM, et al. On the role and fate of LPS-dephosphorylating activity in the rat liver. Am J Physiol Gastrointest Liver Physiol 2006;290:G377-85.
20. van Veen SQ, van Vliet AK, Wulferink M, et al. Bovine intestinal alkaline phosphatase attenuates the inflammatory response in secondary peritonitis in mice. Infect Immun 2005;73:4309-14. (Pubitemid 40923175)
21. Whitehouse JS, Riggle KM, Purpi DP, et al. The protective role of intestinal alkaline phosphatase in necrotizing enterocolitis. J Surg Res 2010;163:79-85.
22. Caplan MS, Hedlund E, Hill N, et al. The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats. Gastroenterology 1994;106:346-52. (Pubitemid 24041210)
23. Jilling T, Lu J, Jackson M, et al. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res 2004;55:622-9. (Pubitemid 38405849)
24. Nadler EP, Dickinson E, Knisely A, et al. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 2000;92:71-7. (Pubitemid 30437462)
25. Xu H, Shi Y, Wang J, et al. A heat shock protein 90 binding domain in endothelial nitric-oxide synthase influences enzyme function. J Biol Chem 2007;282:37567-74.
26. Dvorak B, Halpern MD, Holubec H, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002;282:G156-64. (Pubitemid 34650110)
27. Liedel JL, Guo Y, Yu Y, et al. Mother's milk induced Hsp70 expression preserves intestinal epithelial barrier function in an immature rat pup model. Pediatr Res 2011.
28. Musch MW, Sugi K, Straus D, et al. Heat-shock protein 72 protects against oxidant-induced injury of barrier function of human colonic epithelial Caco2/bbe cells. Gastroenterology 1999;117:115-22. (Pubitemid 29297627)
29. Bates JM, Akerlund J, Mittge E, et al. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2007;2:371-82. (Pubitemid 350215326)
30. Lukas M, Drastich P, Konecny M, et al. Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis. Inflamm Bowel Dis 2010;16:1180-6.
31. Heemskerk S, Masereeuw R, Moesker O, et al. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients. Crit Care Med 2009;37:417-23, e411.
32. Akiba Y, Mizumori M, Guth PH, et al. Duodenal brush border intestinal alkaline phosphatase activity affects bicarbonate secretion in rats. Am J Physiol Gastrointest Liver Physiol 2007;293: G1223-33. (Pubitemid 350255037)
33. Khailova L, Dvorak K, Arganbright KM, et al. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2009;297: G940-9.
34. Holmes JL, Van Itallie CM, Rasmussen JE, et al. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns 2006;6:581-8.
35. Saitou M, Furuse M, Sasaki H, et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000;11:4131-42.
36. Kelly N, Friend K, Boyle P, et al. The role of the glutathione antioxidant system in gut barrier failure in a rodent model of experimental necrotizing enterocolitis. Surgery 2004;136:557-66. (Pubitemid 39186567)
37. Patel RM, Myers LS, Kurundkar AR, et al. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am J Pathol 2012;180:1-10.